SS Innovations International, Inc.

SSII

US05453U2033

Biotechnology & Medical Research

Market Closed - OTC Markets Other stock markets 13:05:25 2024-05-23 EDT			5-day change	1st Jan Change
4.15 ^USD	-2.12%		+18.57%	-42.76%

05-15	SS Innovations International, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-29	SS Innovations International, Inc. Achieves Pediatric Milestone with First Infant Pyeloplasty Using SSi Mantra Surgical Robotic System	CI

Avra Medical Robotics, Inc. Appoints Farhan Taghizadeh as Chief Medical Officer, Effective September 15, 2017

September 27, 2017 at 03:36 pm

Effective September 15, 2017, Farhan Taghizadeh who has served as a member of medical advisory board of AVRA Medical Robotics, Inc., since October 1, 2016, was appointed as Chief Medical Officer.

Latest news about SS Innovations International, Inc.

SS Innovations International, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-15	CI
SS Innovations International, Inc. Achieves Pediatric Milestone with First Infant Pyeloplasty Using SSi Mantra Surgical Robotic System	04-29	CI
SS Innovations International, Inc.?s SSi Mantra Surgical Robotic Device Successfully Completes Telesurgery Procedures	04-10	CI
SS Innovations International, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-22	CI
SS Innovations? SSi Mantra Surgical Robotic System used to perform Mitral Valve Replacement	03-12	CI
SS Innovations International, Inc. announced that it has received $1 million in funding from Sushruta Pvt. Ltd	02-13	CI
Ss Innovations International, Inc. Announces Filing of Pre-Submission Application to the Center for Devices and Radiological Health of the United States Food and Drug Administration	01-26	CI
SS Innovations International, Inc. Announces Strategic Partnership with Surgical Lab for Distribution in Africa	12-26	CI
SS Innovations International, Inc. Announces Successful Completion of 500 Robotic Surgery Using the Company's Innovative SSi Mantra Surgical Robotic System	11-27	CI
SS Innovations International, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-13	CI
SS Innovations International, Inc. Appoints Sonia Shokeen as Head of Quality and Regulatory Affairs	23-10-30	CI
SS Innovations Enters Licensing Agreement with Johns Hopkins University	23-10-16	CI
SS Innovations International, Inc. Appoints Colin Eke to Lead Global Business Development	23-10-06	CI
SS Innovations International, Inc. Launches Innovative Robotic Cardiac Surgery Program in India	23-10-03	CI
SS Innovations International, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-07	CI
SS Innovations International, Inc. Announces Board Appointments	23-08-07	CI
Government Institution Adopts SS Innovations International, Inc.'s SSi Mantra Surgical Robotic System	23-06-30	CI
SS Innovations International, Inc. Auditor Raises 'Going Concern' Doubt	23-06-25	CI
CardioVentures, Inc. (SSI-DE) completed the acquisition of AVRA Medical Robotics, Inc. for $10.9 million in a reverse merger transaction.	23-04-13	CI
AVRA Medical Robotics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-31	CI
AVRA Medical Robotics, Inc. Auditor Raises 'Going Concern' Doubt	23-03-30	CI
AVRA Medical Robotics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-30	CI
AVRA Medical Robotics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-11-30	CI
CardioVentures, Inc. (SSI-DE) entered into non-binding letter of intent to acquire AVRA Medical Robotics, Inc. in a reverse merger transaction.	22-11-06	CI
AVRA Medical Robotics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-11-04	CI

Chart SS Innovations International, Inc.

Duration

Period

Chart SS Innovations International, Inc.

More charts

SS Innovations International, Inc. is a developer of surgical robotic technologies. The Company is developing a fully autonomous medical robotic system using software, which integrates artificial intelligence (AI) and deep learning, or machine learning (DL). Its product range includes its SSI Mantra surgical robotic system, and SSI Mudra is its range of surgical instruments capable of supporting a variety of surgical procedures, including robotic cardiac surgery. Its instruments under development include NADI-Automated Coronary Anastomotic Connector, SSi Multi-Fire Clip Applier, SSi Ultrasonic Surgical Device, SSi Maya-XR Pre-Operative Simulator, SSi Holographic Anatomy, SSi Yog-Tele Proctor, SSi Chitrasa-Advanced DICOM Viewer and SSi Mixed Reality Headset. The SSi Mantra is comprised of vision cart, which provides an additional 32-inch 3D 4K resolution monitor, identical to the surgeonâs console, for the operating room staff.

Sector

Biotechnology & Medical Research

More about the company

Income Statement Evolution

More financial data

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
SS INNOVATIONS INTERNATIONAL, INC.	-42.76%	709M
MODERNA, INC.	+67.53%	63.85B
IQVIA HOLDINGS INC.	-0.77%	41.83B
LONZA GROUP AG	+45.66%	40.65B
CELLTRION, INC.	-10.72%	27.12B
ICON PUBLIC LIMITED COMPANY	+13.30%	26.52B
ALNYLAM PHARMACEUTICALS, INC.	-22.79%	18.69B
BIO-TECHNE CORPORATION	+4.70%	12.73B
UNITED THERAPEUTICS CORPORATION	+24.10%	12.11B
MEDPACE HOLDINGS, INC.	+27.41%	12.07B